Prostate cancer prevention. the current trends


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The interest in the prostate cancer prevention is associated with high incidence and slow growth of tumor. Despite the lack of clinical guidelines for prostate cancer prevention, more and more studies are carried out dedicated to this topic. Since prostate cancer prevention requires prolonged use, the substances derived from food are seems to be the most appropriate. The two most well-known and studied substances are indole-3-carbinol (I3C), obtained from cruciferous plants, and epigallocatechin-3-gallate (EGCG), contained in green tea. As a source of I3C and EGCG, it is possible to use a dietary supplement ProstaDoz. It also included an extract of fruits of dwarf palm, vitamin E, zinc, selenium. ProstaDoz has virtually no contraindications, has no toxic influence, even with prolonged use, does not cause adverse events and can be considered as a promising preventive and therapeutic agent for prostate cancer and prostatic intraepithelial neoplasia (PIN).

Full Text

Restricted Access

About the authors

E. I Karpov

GBU RO «City policlinic №6»; MC “Harmony”

Ph.D., urologist, Chief

References

  1. Ferlay J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 2015. 136:E359.
  2. Пальцев М.А., Киселев В.И., Муйжнек Е.Л. Молекулярные мишени в профилактике и лечении гиперплазии и рака предстательной железы. М.: Изд-во Димитрейд График Групп, 2009. 484 с.
  3. Клинические рекомендации Европейской ассоциации урологов. 2018
  4. Thompson I. M. Jr., Goodman P.J., Tangen C. M., et al. Long-Term Survival of Participants in the Prostate Cancer Prevention Trial. N Engl J Med. 2013;369:603-610.
  5. Klein E.A., Thompson I.M., Lippman S.M., Goodman P.J., Albanes D., Taylor Ph.R., Coltman C. SELECT: the selenium and vitamin E. cancer prevention trial. Urol. Oncol. 2003;21:59-65.
  6. Gaziano M., Glynn R.J., Christen W.G. et al. Vitamins E. and C. in the Prevention of Prostate and Total Cancer in Men: The Physicians’ Health Study II, a Randomized Controlled Trial. JAMA. 2009;301(1): 52-62.
  7. Leitzmann M.F., Stampfer M.J., Michaud D.S. et al. Dietary intake of omega-3 and omega-6 fatty acids and the risk of prostate cancer. Am J. Clin Nutr. 2004; 80:204-216.
  8. Michnovicz J.J., Bradlow H.L. Induction of estradiol metabolism by dietary indole-3-carbinol in humans. Int J. Obes Relat Metab Disord, 1998. 22(3): Р. 227-229.
  9. Wattenberg L.W., Laub W.D. Inhibitors of polycyclic hydrocarbon induced neoplasia by naturally occurring indoles. Cancer Res. 1978;38:1410-1413.
  10. Chinni S.R., Sarkar F.H. Akt inactivation is a key event in indole-3carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res. 2002;8(4):1228-1236.
  11. Brandi G., Paiardini M., Cervasi В., et al. A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines. Cancer Res. 2003;15:63(14):4028-4036.
  12. Cover С.М., Hsieh S.J., Cram E.J. et al. lndole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells. Cancer Res. 1999;15: 59(6): 1244-1251.
  13. Coll D.A., Rosen C.A., Auborn K. et al. Treatment of recurrent respiratory papillomatosis with indole-3-carbinol. Am J. Otolaryngol. 1997;18(4): 283-285.
  14. Stanley M. Genital human papillomavirus infections-current and prospective therapies. J. Natl Cancer Inst Monogr. 2003;31:117-124.
  15. Солдатский Ю.Л., Киселев В.И., Онуфриева Е.К. и др. Анализ эффективности противорецидивной терапии ювенильного респираторного папилломатоза при помощи индинола. Вестник оториноларингологии. 2006;1:46-48
  16. Rosen C.A., Bryson P.C. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J. Voice. 2004;18(2):248-253.
  17. Chinni S.R., Sarkar F.H. Akt inactivation is a key event in indole-3carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res. 2002;8(4): 1228-1236.
  18. Michnovicz J.J. Environmental modulation of estrogen metabolism in humans. Int. Clin. Nutr. Intern J. Obesity. 1998;22:227-229.
  19. Michnovicz J.J., Adlercreutz H., Bradlow H.L. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J. Natl Cancer Inst. 1997;89(1):718-723.
  20. Nelson W.G., De-Marzo A.M., Isaacs W.B. Prostate cancer. N. Engl J. Med. 2003;349:366-381.
  21. Jeong W.S., Kim I.W., Hu R. et al. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm Res. 2004;21(4): 661-670.
  22. Vayalil P.K., Katiyar S.K. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells. Prostate. 2004;59(1):33-42.
  23. Garbisa S., Sartor L., Biggin S., et al. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer. 2001;91:822-832.
  24. Tang F.Y., Nguyen N., Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J. Cancer. 2003;10 106(6): 871-878.
  25. Shaheen R.M., Davis D.W., Liu W. et al. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res. 1999;59(21):5412-5416.
  26. Bettuzzi S. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with highgrade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006;66:1234-1240.
  27. Bettuzzi S., Brausi M. et al. Chemopreventation of human prostate cancer by oral administration of green tea catehinahius in volonteers with high-grade PIN: Apreliminary report from a one-year proof-of-principle study. Cancer Res. 2006;66(2):1234-1240.
  28. Brausi M., Rizzi F., Bettuzzi S. Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur Urol. 2008;54(2):472-473.
  29. Аляев Ю.Г., Рапопорт Л.М., Цариченко Д.Г. и др. Простадоз - возможность превентивной терапии рака простаты? Урология. 2015;6
  30. Рапопорт Л.М., Цариченко Д.Г., Ганжа Т.М. Роль средства ПростаДоз в cпредотвращении рака предстательной железы при простатической интраэпителиальной неоплазии высокой степени. Эффективная фармакотерапия. Урология и Нефрология. 2017;4(34

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies